Fordyce Marshall (CIK 0001859453)

Latest company ownership

Shares held
1,875
Last filed at
Oct 25, 2024
Confidence Score
49.6
2025Q4
Confidence Score History
2022Q3 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Feb 21, 2025 Feb 27, 2025 Vera Therapeutics, Inc. CEO Sell 35.0 -19,688 -4.41% $546.9K
Jan 8, 2025 Jan 10, 2025 Vera Therapeutics, Inc. CEO Sell 38.8 -17,500 -2.61% $730.5K
Dec 18, 2024 Dec 20, 2024 Vera Therapeutics, Inc. CEO Sell 38.8 -17,500 -2.61% $753.7K
Dec 11, 2024 Dec 13, 2024 Vera Therapeutics, Inc. CEO Sell 35.0 -17,500 -3.00% $821.5K
Nov 25, 2024 Nov 27, 2024 Vera Therapeutics, Inc. CEO Sell 38.8 -19,375 -2.89% $929.6K
Nov 13, 2024 Nov 15, 2024 Vera Therapeutics, Inc. CEO Sell 36.3 -30,625 -2.98% $1.5M
Oct 23, 2024 Oct 25, 2024 Vera Therapeutics, Inc. CEO Sell 42.5 -19,375 -1.55% $782.6K
Oct 9, 2024 Oct 11, 2024 Vera Therapeutics, Inc. CEO Sell 38.8 -15,625 -2.47% $597.6K
Sep 25, 2024 Sep 27, 2024 Vera Therapeutics, Inc. CEO Sell 42.5 -23,125 -0.68% $1.1M
Sep 11, 2024 Sep 13, 2024 Vera Therapeutics, Inc. CEO Sell 38.8 -15,625 -2.47% $585.9K
Aug 28, 2024 Aug 30, 2024 Vera Therapeutics, Inc. CEO Sell 36.3 -30,320 -2.35% $1.1M
Aug 21, 2024 Aug 23, 2024 Vera Therapeutics, Inc. CEO Sell 35.0 -14,471 -4.29% $575.4K
Aug 14, 2024 Aug 16, 2024 Vera Therapeutics, Inc. CEO Sell 35.0 -15,625 -4.43% $586.9K
Aug 21, 2023 Aug 23, 2023 Vera Therapeutics, Inc. CEO Sell 41.3 -5,210 -2.10% $86.8K
Oct 3, 2022 Oct 5, 2022 Vera Therapeutics, Inc. CEO Sell 35.0 -32,000 -3.41% $668.8K
Sep 13, 2022 Sep 14, 2022 Vera Therapeutics, Inc. CEO Sell 30.0 -22,363 -5.81% $473.2K
Sep 9, 2022 Sep 13, 2022 Vera Therapeutics, Inc. CEO Sell 30.0 -29,022 -5.07% $592.8K
Sep 7, 2022 Sep 9, 2022 Vera Therapeutics, Inc. CEO Sell 30.0 -21,891 -5.70% $445.9K
Sep 1, 2022 Sep 6, 2022 Vera Therapeutics, Inc. CEO Sell 30.0 -34,196 -5.92% $721.2K
Aug 12, 2022 Aug 15, 2022 Vera Therapeutics, Inc. CEO Sell 22.5 -20,528 -13.00% $413.8K